Loading...
Loading...
Cytori
CYTX
has received 510(k) clearance from the U.S. Food and Drug
Administration (FDA) for the Puregraft(R) 850 System for body
contouring using a patient's own fat. The Puregraft(R) 850 product
line extension provides optimized and sterile processing of up to 850
mL of tissue, a significantly larger volume than the Puregraft(R)
250, which received a 510(k) in January 2010. Larger tissue volumes
expand the range of soft tissue procedures for which the product line
may be used.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in